374 related articles for article (PubMed ID: 30104121)
1. Synthesis, molecular docking, and biological activity of 2-vinyl chromones: Toward selective butyrylcholinesterase inhibitors for potential Alzheimer's disease therapeutics.
Makhaeva GF; Boltneva NP; Lushchekina SV; Rudakova EV; Serebryakova OG; Kulikova LN; Beloglazkin AA; Borisov RS; Richardson RJ
Bioorg Med Chem; 2018 Sep; 26(16):4716-4725. PubMed ID: 30104121
[TBL] [Abstract][Full Text] [Related]
2. 9-Substituted acridine derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors possessing antioxidant activity for Alzheimer's disease treatment.
Makhaeva GF; Lushchekina SV; Boltneva NP; Serebryakova OG; Rudakova EV; Ustyugov AA; Bachurin SO; Shchepochkin AV; Chupakhin ON; Charushin VN; Richardson RJ
Bioorg Med Chem; 2017 Nov; 25(21):5981-5994. PubMed ID: 28986116
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, molecular docking and biological evaluation of N,N-disubstituted 2-aminothiazolines as a new class of butyrylcholinesterase and carboxylesterase inhibitors.
Makhaeva GF; Boltneva NP; Lushchekina SV; Serebryakova OG; Stupina TS; Terentiev AA; Serkov IV; Proshin AN; Bachurin SO; Richardson RJ
Bioorg Med Chem; 2016 Mar; 24(5):1050-62. PubMed ID: 26827140
[TBL] [Abstract][Full Text] [Related]
4. Design, Synthesis, and Evaluation of Acetylcholinesterase and Butyrylcholinesterase Dual-Target Inhibitors against Alzheimer's Diseases.
Guo Y; Yang H; Huang Z; Tian S; Li Q; Du C; Chen T; Liu Y; Sun H; Liu Z
Molecules; 2020 Jan; 25(3):. PubMed ID: 31979317
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, Characterization and Cholinesterase Inhibition Studies of New Arylidene Aminothiazolylethanone Derivatives.
Channar PA; Shah MS; Saeed A; Khan SU; Larik FA; Shabir G; Iqbal J
Med Chem; 2017; 13(7):648-653. PubMed ID: 28266279
[TBL] [Abstract][Full Text] [Related]
6. Flavonols and 4-thioflavonols as potential acetylcholinesterase and butyrylcholinesterase inhibitors: Synthesis, structure-activity relationship and molecular docking studies.
Mughal EU; Sadiq A; Ashraf J; Zafar MN; Sumrra SH; Tariq R; Mumtaz A; Javid A; Khan BA; Ali A; Javed CO
Bioorg Chem; 2019 Oct; 91():103124. PubMed ID: 31319297
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and anticholinesterase activity of new substituted benzo[d]oxazole-based derivatives.
Pouramiri B; Moghimi S; Mahdavi M; Nadri H; Moradi A; Tavakolinejad-Kermani E; Firoozpour L; Asadipour A; Foroumadi A
Chem Biol Drug Des; 2017 May; 89(5):783-789. PubMed ID: 27863021
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and Biological Evaluation of New Cholinesterase Inhibitors for Alzheimer's Disease.
Hussein W; Sağlık BN; Levent S; Korkut B; Ilgın S; Özkay Y; Kaplancıklı ZA
Molecules; 2018 Aug; 23(8):. PubMed ID: 30110946
[TBL] [Abstract][Full Text] [Related]
9. Syntheses, cholinesterases inhibition, and molecular docking studies of pyrido[2,3-b]pyrazine derivatives.
Hameed A; Zehra ST; Shah SJ; Khan KM; Alharthy RD; Furtmann N; Bajorath J; Tahir MN; Iqbal J
Chem Biol Drug Des; 2015 Nov; 86(5):1115-20. PubMed ID: 25951978
[TBL] [Abstract][Full Text] [Related]
10. New piperidine-hydrazone derivatives: Synthesis, biological evaluations and molecular docking studies as AChE and BChE inhibitors.
Karaman N; Sıcak Y; Taşkın-Tok T; Öztürk M; Karaküçük-İyidoğan A; Dikmen M; Koçyiğit-Kaymakçıoğlu B; Oruç-Emre EE
Eur J Med Chem; 2016 Nov; 124():270-283. PubMed ID: 27592396
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of 4-arylcoumarins as potential anti-Alzheimer's disease agents.
Yun Y; Yang J; Miao Y; Wang X; Sun J
Bioorg Med Chem Lett; 2020 Feb; 30(4):126900. PubMed ID: 31882295
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Novel Dual Acetyl- and Butyrylcholinesterase Inhibitors as Potential Anti-Alzheimer's Disease Agents Using Pharmacophore, 3D-QSAR, and Molecular Docking Approaches.
Pang X; Fu H; Yang S; Wang L; Liu AL; Wu S; Du GH
Molecules; 2017 Jul; 22(8):. PubMed ID: 28933746
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, structure-activity relationship and molecular docking of 3-oxoaurones and 3-thioaurones as acetylcholinesterase and butyrylcholinesterase inhibitors.
Mughal EU; Sadiq A; Murtaza S; Rafique H; Zafar MN; Riaz T; Khan BA; Hameed A; Khan KM
Bioorg Med Chem; 2017 Jan; 25(1):100-106. PubMed ID: 27780618
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of benzofuran appended benzothiazepine derivatives as inhibitors of butyrylcholinesterase and antimicrobial agents.
Mostofi M; Mohammadi Ziarani G; Lashgari N
Bioorg Med Chem; 2018 Jul; 26(12):3076-3095. PubMed ID: 29866481
[TBL] [Abstract][Full Text] [Related]
15. Discovery of isoalloxazine derivatives as a new class of potential anti-Alzheimer agents and their synthesis.
Kanhed AM; Sinha A; Machhi J; Tripathi A; Parikh ZS; Pillai PP; Giridhar R; Yadav MR
Bioorg Chem; 2015 Aug; 61():7-12. PubMed ID: 26042530
[TBL] [Abstract][Full Text] [Related]
16. Novel N-benzylpyridinium moiety linked to arylisoxazole derivatives as selective butyrylcholinesterase inhibitors: Synthesis, biological evaluation, and docking study.
Vafadarnejad F; Karimpour-Razkenari E; Sameem B; Saeedi M; Firuzi O; Edraki N; Mahdavi M; Akbarzadeh T
Bioorg Chem; 2019 Nov; 92():103192. PubMed ID: 31446239
[TBL] [Abstract][Full Text] [Related]
17. Novel 2-pheynlbenzofuran derivatives as selective butyrylcholinesterase inhibitors for Alzheimer's disease.
Kumar A; Pintus F; Di Petrillo A; Medda R; Caria P; Matos MJ; Viña D; Pieroni E; Delogu F; Era B; Delogu GL; Fais A
Sci Rep; 2018 Mar; 8(1):4424. PubMed ID: 29535344
[TBL] [Abstract][Full Text] [Related]
18. Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer's disease: In vitro studies against yeast α-glucosidase, acetylcholinesterase and butyrylcholinesterase.
Riaz S; Khan IU; Bajda M; Ashraf M; Qurat-Ul-Ain ; Shaukat A; Rehman TU; Mutahir S; Hussain S; Mustafa G; Yar M
Bioorg Chem; 2015 Dec; 63():64-71. PubMed ID: 26451651
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics.
Kwon YE; Park JY; No KT; Shin JH; Lee SK; Eun JS; Yang JH; Shin TY; Kim DK; Chae BS; Leem JY; Kim KH
Bioorg Med Chem; 2007 Oct; 15(20):6596-607. PubMed ID: 17681794
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of pyrano[4,3-b][1]benzopyranone derivatives as monoamine oxidase and cholinesterase inhibitors.
Takao K; Kubota Y; Kamauchi H; Sugita Y
Bioorg Chem; 2019 Mar; 83():432-437. PubMed ID: 30428433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
